Article · Volume 4, Issue 2 · pp. 168–9
The portal for rare diseases and orphan drugs
Jatinder Singh1
- 1Department of Pharmacology, Government Medical College, Amritsar, India.
Abstract
Orphan drugs are the stepchildren of the pharmaceutical industry. These medicinal products that are used primarily for the prevention or treatment of life‑threatening or debilitating rare diseases have restricted markets and thus limited profitability. As a consequence, the pharmaceutical industry has little interest in developing and marketing these drugs which are intended for patients who suffer from rare conditions.
Keywords: Webwise
The full text of this article is available as a PDF. Open the PDF.